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Abstract
The mechanism by which aggregates of the b-amyloid peptide (Ab) mediate their toxicity is uncertain. We show here that the
expression of the 42-amino-acid isoform of Ab (Ab1–42) changes the expression of genes involved in oxidative stress in a
Drosophila model of Alzheimer’s disease. A subsequent genetic screen conﬁrmed the importance of oxidative stress and a
molecular dissection of the steps in the cellular metabolism of reactive oxygen species revealed that the iron-binding protein
ferritin and the H2O2 scavenger catalase are the most potent suppressors of the toxicity of wild-type and Arctic (E22G) Ab1–42.
Likewise, treatment with the iron-binding compound clioquinol increased the lifespan of ﬂies expressing Arctic Ab1–42. The effect
of iron appears to be mediated by oxidative stress as ferritin heavy chain co-expression reduced carbonyl levels in Ab1–42 ﬂies
by 65% and restored the survival and locomotion function to normal. This was achieved despite the presence of elevated levels
of the Ab1–42. Taken together, our data show that oxidative stress, probably mediated by the hydroxyl radical and generated by
the Fenton reaction, is essential for Ab1–42 toxicity in vivo and provide strong support for Alzheimer’s disease therapies based on
metal chelation.
Introduction
There is a growing consensus that smaller, soluble aggregates of the
b-amyloid peptide (Ab), rather than mature amyloid plaques, are the
pathogenic species in Alzheimer’s disease (AD) (Lambert et al., 1998;
Walsh et al., 2002). However, the mechanism by which these
aggregates mediate their toxicity remains unclear. As Ab is generated
in the extracellular space, or more likely within the lumen of endocytic
vesicles (Koo & Squazzo, 1994; Refolo et al., 1995), its toxic effects
may be mediated by membrane damage or by interactions with
membrane-bound proteins. There is evidence that Ab aggregates can
degrade the electrical resistance of membranes (Kayed et al., 2004;
Demuro et al., 2005), possibly by forming pores (Lashuel et al.,
2002), or alternatively they may interact with membrane receptors or
even gain access to the cytoplasm. Membranes can also be damaged
by the reactive oxygen species that are generated by Ab aggregates in
the presence of metals such as copper, zinc or iron (Bush, 2003).
Subsequent pathological processes include mitochondrial damage
(Abramov et al., 2004), tau phosphorylation with consequent
axonal transport dysfunction and the initiation of cell death
(Kienlen-Campard et al., 2002; Wei et al., 2002; Jo et al., 2004).
However, until recently (Cao et al., 2008) it has been impossible to
take a global view to ask which biological processes are essential for
the development of the disease and which are downstream conse-
quences of neurotoxicity. Knowing which biological processes are
directly involved in initiating AD will allow us to focus on those
upstream targets that have the greatest therapeutic potential.
We have developed a model of AD that is based on the expression
of the human Ab in ﬂy neurons by coupling it to an N-terminal
secretion signal peptide (Crowther et al., 2005). The Ab1–42 but not
the Ab1–40 control accumulates in the brain and results in decreased
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more marked in ﬂies expressing the E22G (Arctic) mutant of the
Ab1–42, which causes increased aggregation of Ab and is responsible
for early onset familial AD (Nilsberth et al., 2001). Here, we use our
Drosophila model of AD to identify the pathways and intermediates
that are critical for Ab-mediated toxicity in vivo.
Materials and methods
Drosophila stocks
The following stocks were generous gifts: UAS-CAT [catalase (CAT)
upstream activating sequence (UAS) inducible transgene] (Anderson
et al., 2005), UAS-SOD1 [CuZn-superoxide dismutase (SOD)1]
(Anderson et al., 2005), UAS-SOD1-IR (RNAi line for SOD1)
(Missirlis et al., 2003) and UAS-mitSOD2 (Mn-SOD2) (Anderson
et al., 2005) from Professor John Phillips (Guelph, Canada),
UAS-Sniffer (carbonyl reductase) (Botella et al., 2004) from Professor
Stephan Schneuwly (Regensburg, Germany) and UAS-GST [glutathi-
one-S-transferase (GST) S1] (Whitworth et al., 2005) from Dr Alex
Whitworth (Shefﬁeld, UK). We used previously characterized
UAS-CAT, UAS-SOD1 and UAS-mitSOD2 stocks (Anderson et al.,
2005) as they increase enzymatic activity by up to 200%. Stocks of
mutant SOD1
n108 (Phillips et al., 1995) and elav
c155-GAL4 were from
the Bloomington stock centre (Indiana, USA). Flies carrying Ab
transgenes [Ab1–40 (Alz40.1), Ab1–42 (Alz42.2 and Alz42.3)o rArctic
Ab1–42 (AlzArc1)] have been described previously (Crowther et al.,
2005; Luheshi et al., 2007). The transgenes are each representative of
sixindependenttransgeniclinesandeachtransgenedrivessimilarlevels
ofmRNAwhetheraloneorincombination(suchasAlz42.2 + Alz42.3).
DNA constructs
The cDNA for Drosophila ferritin 1 heavy chain (Fer1HC) was
isolated from EST clone GH24060 (Berkley Drosophila Genome
Project). This cDNA lacked the iron response element resulting in the
expression of a constitutively active form of Fer1HC. The cDNA for
Drosophila ferritin 2 light chain (Fer2LC) naturally lacks an iron
response element and was isolated from the EST clone AT16780
(Berkley Drosophila Genome Project). Both cDNAs were inserted
downstream of GAL4 UASs (UAS-Fer1HC and UAS-Fer2LC) in the
pUAST plasmid by directional cloning following EcoRI and XhoI
digestion.
Affymetrix cDNA microarray
Individual samples were each hybridized to a Drosophila Genome
GeneChip
  Array following standard Affymetrix protocols. Affyme-
trix Microarray Suite 5 was used to generate signal values and
detection calls. Probe level intensity data were adjusted for back-
ground, normalized and log transformed using the robust multichip
average pre-processing method (Irizarry et al., 2003) using Rosetta
Resolver
  7.1.
Ratio data for each individual probe were created as follows. Ab1–40
baseline samples were created for each time-point by pooling all
replicates (see Supplementary material, Fig. S1a). The individual
replicates for each test condition (Arctic Ab1–42 and Ab1–42) were then
compared with the age-matched control Ab1–40 pool. All statistical
analyses were performed on log10 ratio data.
Gene expression differences were determined by one-way, error-
weighted anova on ratio data by comparing Ab1–42 and Arctic
mutants with age-matched Ab1–40 controls (factor = genotype, n =4
per group). Genes were only considered in the analysis of over-
represented biological themes if the differential expression was highly
signiﬁcant (P < 0.01).
Characterization of over-represented biological themes
Gene Ontology (Ashburner et al., 2000) enrichment analysis was
performed using the Gene Ontology tree machine (http://bioinfo.van-
derbilt.edu/gotm/) (Zhang et al., 2004). In summary, a hypergeometric
test was performed to determine whether a particular biological
process or molecular function was disproportionately represented in
the set of genes that were differentially expressed as compared with all
of the genes in the GeneChip
  array. Where n = number of genes that
are differentially expressed between two experimental conditions (e.g.
between Arctic Ab1–42 and Ab1–40 on day 0), N = total number of
genes on the array, K = number of genes on the array that belong to
the category of interest and k = number of genes that belong to the
category that are differentially expressed, the signiﬁcance (P)o f
enrichment for a given category is determined by
P ¼
X n
i¼k
N   K
n   i
  
K
i
  
N
n
  
A ratio of enrichment, R, is calculated as R = k⁄ke where
ke =( n⁄N)K is the expected value for a given category if n = number
of genes were a random sample of uniformly selected genes from the
reference set of all genes on the chip.
Gene Search element screen
A library of 3000 unique insertions of the Gene Search (GS) element
was generated by mobilizing the GS element from the X chromosome
(DGRC number 200079) to the autosomes by crossing with ﬂies
expressing the Delta2-3 transposase. The ﬁrst eclosed ﬂy with a
stably-jumped GS element from each mobilization cross was used to
establish a GS line. Stocks were maintained by monitoring eye colour.
The effect of the Gal-4 activated GS element on the longevity of ﬂies
expressing the Arctic mutant of Ab1–42 was determined by crossing
male ﬂies with elav
c155-Gal4 (elav-Gal4) on the X chromosome and
the Arctic Ab1–42 transgene on the second chromosome with virgin
females with a ﬂoating GS element. All of the female offspring had
both elav-Gal4 and the Arctic Ab1–42 transgene but only half had the
GS element; the unmodiﬁed population (without the GS element)
provided an internal control for each longevity assay. The null
hypothesis was that the presence of the GS element made no
difference to the longevity of the ﬂies expressing the Arctic Ab1–42
transgene.
Longevity assays for the primary screen were performed at 25 C,
blind to the identity of the GS elements. Live ﬂies were counted and
the food changed on days 1, 3 and 5 of a 7 day cycle. A mean number
of 17 ﬂies was assessed per GS line (total number of ﬂies assessed,
50 320; minimum number of ﬂies assessed per GS line, 10). To detect
suppression of the longevity phenotype we determined the time to
75% death, which is the median survival of the ﬂies in which the GS
element has prolonged their life. These survival times were normally
distributed (n = 2893, mean 21.6 days, SD 3.8 days) and any lifespan
that was more than two SDs greater than the mean was deﬁned as
signiﬁcant.
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determined by classical genetics and homozygous GS ﬂies were
crossed so that all ﬂies in the longevity assays expressed the activated
GS element. This secondary screen used homozygous GS element
stocks and assessed more than 30 ﬂies, permitting robust comparison
of the survival of GS-modiﬁed and unmodiﬁed Arctic Ab1–42 ﬂies.
The site of the GS element insertion was identiﬁed in those lines with
conﬁrmed modiﬁer activity by inverse polymerase chain reaction
using the FlyChip facility (http://www.drosdel.org.uk/molecu-
lar_methods.php). The molecular function of genes with inserts within
the coding sequence was determined from FlyBase. For inserts in non-
coding DNA, the molecular function was determined for the genes on
either side of the insert. The effect of the activated GS element on the
survival of control ﬂies and ﬂies expressing the AlzArc1 transgene was
also determined. GS lines in which the modiﬁcation of the Ab
longevity phenotype was not conﬁrmed or in which the GS element
had a marked non-speciﬁc effect on control ﬂies were discarded.
Longevity assays for the secondary screen and genetic modiﬁer
assessment
Longevity assays in the secondary screen and for each of the
subsequent genetic modiﬁers followed at least 80 ﬂies per genotype in
groups of 10 ﬂies per vial. Live ﬂies were counted and their food
changed on days 1, 3 and 5 of a 7 day cycle. For assessing the efﬁcacy
of metal chelation, clioquinol (Calbiochem) was dissolved in
dimethylsulphoxide and the solution added to ﬂy food to give a ﬁnal
concentration of 0.2% v⁄v. Survival curves were plotted using the
Kaplan–Meier estimator. The statistical signiﬁcance was calculated
using the log rank test within the spss 11.0 statistical package. The
null hypothesis in all of the longevity assays was that the presence of
the GS element made no difference to the longevity of the ﬂies
expressing the Arctic Ab1–42 transgene.
Assay of sensorimotor performance
The sensorimotor performance of the ﬂies was determined using a
previously described negative geotaxis assay (Rival et al., 2004).
Fifteen ﬂies were placed in a sterile plastic column (25 cm
tall · 1.5 cm internal diameter) and tapped to the bottom. After 45 s
the ﬂies at the top of the column (Ntop) and the ﬂies remaining at the
bottom (Nbot) were counted. Three trials were performed at 1 min
intervals. The performance index was deﬁned as (15 + Ntop–Nbot)⁄30.
Statistical analysis was performed using the two-tailed Student’s t-test.
Quantitation of b-amyloid peptides
Drosophila were cultured at 25 C for 5 days after eclosion and then
ﬁve heads were homogenized in 50 lLo f5m guanidinium HCl,
5m m EDTA and 50 mm hepes, pH 7.3. Following centrifugation for
5 min at 12 000 g,2 0lL of the clear supernatant was removed and
mixed with 180 lLo f2 5m m HEPES, pH 7.3, 1 mm EDTA and 0.1%
w⁄v bovine serum albumin with protease inhibitors (Complete ,
Roche). Triplicate 25 lL aliquots were mixed with an equal volume of
phosphate-buffered saline containing 2% w⁄v bovine serum albumin,
0.2% v⁄v Tween-20 and protease inhibitors (Complete , Roche) in
wells on a MESO microtitre plate (Standard bind, MA6000, no.
P11AA-1; Meso Scale Discovery, MD, USA). The reaction was
started by adding 25 lLo f4lg⁄mL solutions of biotinylated 6E10 or
4G8 (Signet Laboratories, MA, USA) monoclonal antibodies. After
mixing a further 25 lL aliquot of 1 lg⁄mL Ruthenium-labelled
G2-10 or G2-11 (The Genetics Company, Switzerland), monoclonal
antibody solution was added to each well. Following an overnight
incubation at 25 C, the plates were washed twice with phosphate-
buffered saline, 150 lL of S Read Buffer (R92SC-1, Meso Scale
Discovery, MD, USA) was added and the measurement was taken in a
Sector PR instrument (Meso Scale Discovery). Statistical analysis was
performed using the two-tailed Student’s t-test.
Hydrogen peroxide sensitivity assay
Two-day-old ﬂies were cultured in a vial containing only ﬁlter paper
soaked in an aqueous solution of 2% w⁄v sucrose and 10% v⁄vH 2O2
or a control solution of 2% w⁄v sucrose alone. Ten vials of 15 ﬂies
were cultured for each genotype at 25 C with the soaked paper being
replaced twice per day. Statistical analysis was performed using the
two-tailed Student’s t-test.
Carbonyl assay
Five adult ﬂies (28 days old, grown at 25 C) were decapitated and the
heads were immediately homogenized in water, sonicated and
centrifuged at 12 000 g for 10 min and the clear supernatant assayed
for protein content using the Bradford method. The protein concen-
tration was adjusted to 5 lg⁄mL by the addition of phosphate-
buffered saline. Protein carbonyl groups were assayed using an
enzyme-linked immunosorbent assay-based protocol described by
Alamdari et al. (2005). Protein carbonyl groups were reacted with
dinitrophenol hydrazine (Sigma-Aldrich) and the resulting dinitrophe-
nol adducts were detected using an anti-DNP rabbit polyclonal
antibody (Sigma-Aldrich). Statistical analysis was performed using the
two-tailed Student’s t-test.
Iron and zinc determination in ﬂy head extracts by mass
spectrometry
Flies were cultured at 29 C and decapitated at 10 days old. Triplicates
of 20 ﬂy heads per condition were weighed by difference into a new
15 mL screw-top polypropylene centrifuge tube (part no. 2086-500,
Elkay, UK). Nitric acid (500 lL) (‘Trace Select’, part no. 84385,
Fluka, UK) was added and the tubes were sealed and incubated
overnight at 65 C such that there was no visible solid matter
remaining. The sample was prepared by resuspending the extracts in
5 mL of double-distilled water before analysis using an Elan 6100
DRC ICP⁄MS (Perkin-Elmer). The reaction cell was used for all
measurements with the following operating conditions: 1.04 L⁄min
nebulizer ﬂow, 1100 W radio frequency power and a dynamic reaction
cell gas ﬂow of 0.7 mL⁄min of ammonia. Iron (Mr 55.9349), zinc (Mr
65.9260) and calcium (Mr 43.9555), but not copper (Mr 62.9298),
were reliably detected. As calcium is not chelated by clioquinol it was
used to control for the quantity of tissue in each sample.
Results
Microarray analysis of gene expression in ﬂies expressing
b-amyloid peptide supports the importance of oxidative stress
in b-amyloid peptide toxicity
Affymetrix microarrays were used to identify gene expression
signatures (one-way anova, P < 0.001) for ﬂies expressing wild-
type Ab1–42 at day 0, 3 and 8 of adult life and Arctic Ab1–42 at day 0
and 3 by comparison to age-matched Ab1–40 controls. The derived
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European Journal of Neuroscience, 29, 1335–1347Fig. 1. The expression signature of genes for ﬂies expressing Ab1–42 at day 3 (top part) and day 8 (bottom part) of adult life was determined and analysed for over-
representation of genes belonging to particular molecular functions. Only functional groups that are signiﬁcantly over-represented in the set of differentially regulated
genes (P < 0.01) are depicted. The bars represent the ratio of enrichment (R), calculated as the ratio between the observed (O) number of genes belonging to a
molecular function and the expected number of genes belonging to that function if selected at random. Molecular functions that are clearly redox-related are
represented by shaded bars; other molecular functions are represented by open bars.
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Ab1–42 were then used to determine the biological processes,
molecular functions and cellular components that were over-repre-
sented in each set (in supplementary Fig. S1b). The role of redox
genes appeared most apparent in the early stages of Ab1–42 expression
(Fig. 1); this is most clearly seen for ﬂies expressing wild-type Ab1–42
at day 3 (top part, shaded) where these genes comprised six of the 10
families of enriched genes. Genes that were classiﬁed as having
‘oxidoreductase activity’ were signiﬁcantly enriched at both day 3 and
8 in ﬂies expressing wild-type Ab1–42 (P < 0.01). Similarly, carbonyl
reductase (NADPH) activity was enriched in the day 3 signature of
ﬂies expressing Arctic Ab1–42 (P < 0.01). Taken together, these obser-
vations provide strong support for the role of oxidative stress-related
genes in the response of the ﬂy brain to the expression of the Ab.
P-element screen for modiﬁers of b-amyloid peptide toxicity
implicate redox regulation as an important target of modiﬁer
activity
A 3000-line library of unique GS (Toba et al., 1999) element inserts
was screened for lines that modiﬁed the longevity of Drosophila
expressing Ab1–42 in their central nervous system. The GS elements
can either disrupt gene function when they insert within essential
coding or non-coding DNA, or else they can bidirectionally upregulate
neighbouring genes. In our screen 1.5% of the GS inserts resulted in an
increase in median survival that was more than two SDs away from the
mean, whereas 0.5% of the inserts signiﬁcantly reduced survival.
A secondary longevity assay was performed to conﬁrm the initial
ﬁndings but also to determine the effect of the GS elements on the
survival of control ﬂies that did not express Ab. The insertions that
speciﬁcally modiﬁed the longevity of Ab-expressing ﬂies, and not
controls, were classiﬁed into 18 suppressor and three enhancer groups
according to the identity of the neighbouring genes. Seven of these 21
classes were adjacent to genes with a predictable role in oxidative stress
(Table 1 and Fig. 2). The selected suppressor GS elements increased
median survival by 25–96% in ﬂies expressing Ab but had no, or little,
effect in control ﬂies (Fig. 2, ﬁlled and empty bars, respectively).
Flies expressing b-amyloid peptide1–42 are more sensitive
to oxidative stress and have higher levels of oxidative damage
The genetic screen and microarray data implicated oxidative stress as
playing a central role in the toxicity of the Ab1–42. This was assessed
Table 1. GS elements inserted within or adjacent to genes involved in oxidative stress modify the toxicity of Arctic Ab
GS elements Gene name Gene identiﬁer Molecular function
GS insertion sites
(range of sequence
locations)
148, 174, 274, 1360, 2225,
2823, 3063
Lethal (2) 01289 CG9432 Thioredoxin-like domain 2252526–2252617
2703, 2521, 3102 Fer1HC and Fer2LC CG2216 and CG1469 Iron chelator and ferroxidase activity 26215006–26215015
532, 1287, 1472.2, 1652,
2484
Fer1HC and Fer2LC CG2216 and CG1469 Iron chelator and ferroxidase activity 26212564–26212784
811 Cyp6a20 Cytochrome
P450-6a9
CG10245 and CG10246 Oxidoreductase activity in steroid
metabolism
10396945
1264, 2155 Carbonyl reductase CG11200 Reduction of aldehydes 15823515–15823522
1357 Orthologues of human
retinol dehydrogenase
CG2064 and CG2065 Short chain dehydrogenases 20961357
1774 Orthologue of human
aldehyde dehydrogenase
4A1 and Hsc70Cb
CG6661 and CG6603 Oxidation of aldehydes and
chaperone
14029850–14036659
Ab, b-amyloid peptide; GS, Gene Search.
Fig. 2. The percentage increase in median survival in ﬂies expressing Arctic
Ab1–42 that was attributable to the GS element was calculated (ﬁlled bars).
Control ﬂies (n = 100) possessing elav-Gal4 ± the GS element but lacking the
Arctic Ab1–42 transgene (n = 100) were also assessed. The percentage increase
in median survival in these control ﬂies that was attributable to the GS element
was determined (empty bars). The signiﬁcance of the greater increase in median
survival in Arctic Ab1–42 vs. the effect on control ﬂies was signiﬁcant
(P < 0.001) in all cases. The number of independent GS element inserts that
were independently identiﬁed in the screen and analysed in this assay is
indicated in white on the ﬁlled bars. Where three or more GS inserts were
available in a particular class the error bars indicate the SD of the estimates. We
assumed that the estimates varied normally and the signiﬁcance was calculated
by Student’s t-test [ferritin light (L) chain inserts, P < 0.05; ferritin heavy (H)
chain inserts, P < 0.001; CG9432, P < 0.001]. DH, dehydrogenase.
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H2O2 in their food. In these experiments we observed that ﬂies
expressing wild-type Ab1–42 were more likely to die if their food was
supplemented with 10% v⁄vH 2O2 than either control ﬂies (Fig. 3a,
elav-Gal4 w
1118 vs. elav-Gal4 UAS-Ab1–42, P < 0.05) or ﬂies
expressing Ab1–40 (Fig. 3a, elav-Gal4 UAS-Ab1–40 vs. elav-Gal4
UAS-Ab1–42, P < 0.05). When we quantiﬁed oxidative damage by
measuring the levels of carbonyl groups in protein extracts of ﬂy heads
we found that ﬂies expressing Ab1–40 had carbonyl levels that were
similar to those of control ﬂies (Fig. 3b, elav-Gal4 w
1118 vs. elav-Gal4
UAS-Ab1–40), whereas ﬂies expressing a single Ab1–42 transgene had
almost double the carbonyl levels of ﬂies expressing Ab1–40 (Fig. 3b,
elav-Gal4 UAS-Ab1–42 vs. elav-Gal4 UAS-Ab1–40, P < 0.05).
Transgenic over-expression of single antioxidative stress genes
rescues the b-amyloid peptide-induced longevity phenotype
The ability of antioxidative stress genes identiﬁed in the screen, and
genes from the canonical oxidative stress pathway, to modify the
toxicity of Ab was conﬁrmed in ﬂies by speciﬁcally over-expressing
each transgene in combination with wild-type or Arctic Ab1–42. In this
way we assessed candidate genes from the GS element screen, i.e. the
heavy and light chains of Drosophila ferritin (Fer1HC and Fer2LC)
and carbonyl reductase by over-expression of the Drosophila enzyme
Sniffer (SNI). We also tested candidate genes including cytoplasmic
CuZn-SOD1, the mitochondrial Mn-SOD2 (mitSOD2) and CAT, and
GST (Fig. 4). This approach allowed comparison of the efﬁcacy of the
upstream enzymes that modulate the generation of free radicals
(SOD1, mitSOD2, CAT, Fer1HC and Fer2LC) with the downstream
enzymes that repair oxidative damage (GST and carbonyl reduc-
tase⁄SNI).
Over-expression of ferritin heavy chain resulted in a 105% increase
in median survival of Arctic Ab1–42 ﬂies (P < 0.0001), whereas over-
expression of ferritin light chain gave a 49% increase in median
survival (P < 0.0001) (Fig. 4a and b). The most powerful canonical
oxidative stress-related protein was CAT, which increased the median
survival of Arctic Ab1–42 ﬂies by 56% (P < 0.0001, Fig. 4a and c).
MitSOD2 prolonged median survival by 18% (P < 0.0001, Fig. 4a
and d). In contrast, and contrary to our expectations, the over-
expression of cytoplasmic SOD1 enhanced the toxicity of Arctic
Ab1–42. Flies expressing mutants of SOD1 that are dominant-negative
for activity were then assessed to see if they had a similar modifying
activity. Co-expression of both the SOD1
n108 mutant and RNAi for
SOD1 resulted in a 43% and 32% increase in median survival,
respectively (Fig. 4a and c), indicating that it is the catalytic activity of
SOD1 that potentiates the toxic effect of the Ab. The protection
afforded by CATcombined with the toxicity of SOD1 suggests that the
uncompensated production of H2O2 is a vital step in the oxidative
stress caused by the Ab. An additional stress resulting from increased
SOD1 activity may be the co-production of O2 by the dismutation of
superoxide radicals. This oxygen may go on to generate further H2O2
by reacting with iron or copper ions that are complexed with Ab
(Huang et al., 1999a,b).
Much smaller protective activities were observed when enzymes,
speciﬁcally Drosophila carbonyl reductase (SNI) and GST, that are
involved in steps further downstream in the pathway were upregulated
(Fig. 4a). Control experiments, in which the antioxidative stress genes
were over-expressed in ﬂies that were identical except that they lacked
the Ab transgene, did not reveal non-speciﬁc prolongation of life
(Fig. 4d). In ﬂies expressing wild-type Ab1–42 we were able to conﬁrm
the prolongation of lifespan by the heavy and light chains of ferritin
and the toxic effect of SOD1 (data not shown).
Transgenic over-expression of single antioxidative stress genes
rescues the b-amyloid peptide-induced locomotor phenotype
The modiﬁers were then assessed for their ability to protect against the
Ab1–42-mediated decline in locomotor function. Flies co-expressing
either ferritin subunit with Arctic Ab1–42 were signiﬁcantly more
mobile than ﬂies expressing Arctic Ab1–42 alone (Fig. 5a, elav-Gal4
Fig. 3. Flies expressing Ab1–42 are more sensitive to oxidative stress and have higher levels of oxidative damage. Supplementing the ﬂy food with 10% v ⁄ vH 2O2
for 72:00 h (a, shaded bars) was speciﬁcally toxic to ﬂies expressing Ab1–42, signiﬁcantly reducing their survival as compared with ﬂies expressing Ab1–40 (a, elav-
Gal4 UAS-Ab1–42 vs. elav-Gal4 UAS-Ab1–40, P < 0.05). H2O2 treatment did not reduce the survival of Ab1–40 as compared with control ﬂies (a, elav-Gal4 w
1118 vs.
elav-Gal4 UAS-Ab1–40). The differences in survival at 72:00 h were not due to toxicity of the Abs because in the absence of H2O2 there was no difference in survival
between any of the groups (open bars). Flies expressing Ab1–42, but not ﬂies expressing Ab1–40 or control ﬂies, exhibited markers of oxidative stress. Measurement
of carbonyl groups (nm ⁄ mg head protein extract) demonstrated that ﬂies expressing Ab1–42 had a signiﬁcantly higher carbonyl load than control ﬂies (b, elav-Gal4
w
1118 vs. elav-Gal4 UAS-Ab1–42, P < 0.05). In ﬂies expressing Ab1–40 the carbonyl load was not signiﬁcantly increased (b, elav-Gal4 UAS-Ab1–40 vs. elav-Gal4
w
1118) above control levels. The data are representative of three independent Ab42 transgenic lines. Independent Student’s t-test result (*P < 0.05, **P < 0.01).
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European Journal of Neuroscience, 29, 1335–1347Fig. 4. Co-expression of antioxidative stress genes with Ab increased the median survival of ﬂies. Co-expression of both ferritin heavy (elav-Gal4 UAS-Fer1HC)
and light (elav-Gal4 UAS-Fer2LC) chains prolonged the lifespan of Arctic Ab1–42 ﬂies (a and b, elav-Gal4 UAS-Arctic Ab42). Flies co-expressing Arctic Ab1–42 and
the heavy chain of ferritin exhibited survival that was similar to that of control ﬂies (b, elav-GAL4). Similarly, co-expression of another gene from the GS screen,
carbonyl reductase (a, elav-Gal4 UAS-SNI), yielded a small but signiﬁcant prolongation of the lifespan of Arctic Ab1–42 ﬂies. The expression of other canonical
antioxidative enzymes also had signiﬁcant effects on longevity. Both mitSOD2 (a, elav-Gal4 UAS-mitSOD2) and CAT (a and c, elav-Gal4 UAS-CAT) prolonged the
lifespan of the ﬂies. Surprisingly, SOD1 (a and c, elav-Gal4 UAS-SOD1) enhanced the toxicity of Arctic Ab1–42. In contrast, the knockdown of endogenous SOD1
protein by UAS-RNAi (a and c, elav-Gal4 UAS-IR.SOD1) protected the ﬂy from Ab toxicity. The enhancer effect of SOD1 appears to be mediated by its catalytic
activity because a dominant negative mutant of SOD1 prolonged the lifespan of the ﬂies expressing Arctic Ab (a and c, SOD1
n108). In control experiments there
was no prolongation of lifespan when SOD1, mitSOD2, CAT, carbonyl reductase, ferritin heavy chain and ferritin light chain were expressed using elav
c155-Gal4 in
ﬂies that did not carry the UAS-Arctic Ab1–42 transgene (d). Kaplan–Meier survival curves were plotted and statistical signiﬁcance was assessed by the log rank test
using the spss 11.0 statistical package. Differences shown were all statistically signiﬁcant (P < 0.001). In control experiments elav-Gal4 ﬂies had the same lifespan
as the background w
1118 ﬂies.
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European Journal of Neuroscience, 29, 1335–1347UAS-Arctic Ab1–42) from day 10 onwards, and both the heavy and
light chain ﬂies performed like control ﬂies (Fig. 5a, elav-Gal4)u pt o
day 25. The effect of the heavy chain was more potent, maintaining
wild-type locomotor performance in Arctic Ab1–42 ﬂies to day 35. The
behavioural effects of over-expressing the canonical antioxidative
genes were in accord with their longevity data; CAT (Fig. 5b,
elav-Gal4 UAS-Arctic Ab1–42 UAS-CAT) and the mitSOD2 (Fig. 5b,
elav-Gal4 UAS-Arctic Ab1–42 UAS-mitSOD2) were suppressors of the
Arctic Ab1–42 locomotor phenotype, whereas the cytoplasmic SOD1
(Fig. 5b, elav-Gal4 UAS-Arctic Ab1–42 UAS-SOD1) accelerated the
decline in locomotor function. Over-expression of the heavy chain of
ferritin (Fig. 5c, elav-Gal4 UAS-Ab1–42 UAS-FerHC) and CAT
Fig. 5. Over-expressing oxidative stress-related genes modiﬁed the Ab-induced locomotor phenotype. Flies expressing Arctic Ab1–42 (a, UAS-Arctic Ab1–42)
exhibited a progressive decline in locomotor function becoming immobile by day 30. Control ﬂies (elav-GAL4) showed a markedly slower decline in locomotor
function (a–d). Co-expression of ferritin heavy (a, UAS-Arctic Ab1–42 UAS-Fer1HC) and light (a, UAS-Arctic Ab1–42 UAS-Fer2LC) chains signiﬁcantly improved
locomotor function. The locomotor effects of the canonical antioxidant genes were in accord with their effects on longevity; CAT (b, UAS-Arctic Ab1–42 UAS-CAT)
and mitSOD2 (b, UAS-Arctic Ab1–42 UAS-mitSOD2) improved climbing, whereas SOD1 (b, UAS-Arctic Ab1–42 UAS-SOD1) accelerated the decline. The antioxidant
genes had similar effects when co-expressed with wild-type Ab1–42 with co-expression of ferritin heavy chain (c, UAS-Ab1–42 UAS-Fer1HC) and CAT
(c, UAS-Ab1–42 UAS-CAT) improving locomotor function and SOD1 (c, UAS-Ab1–42 UAS-SOD1) accelerating the decline in locomotor function. Co-expression of
GST (d, UAS-Arctic Ab1–42 UAS-GST) gave a weak rescue of the locomotor deﬁcits and carbonyl reductase (d, UAS-Arctic Ab1–42 UAS-SNI) did not signiﬁcantly
improve locomotor function. In control experiments the expression of the key modiﬁers of Ab toxicity (FerHC, FerLC and CAT) in the absence of Ab did not have a
beneﬁcial effect on locomotor function at any time-point (supporting Fig. S2) (independent Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001).
1342 T. Rival et al.
ª The Authors (2009). Journal Compilation ª Federation of European Neuroscience Societies and Blackwell Publishing Ltd
European Journal of Neuroscience, 29, 1335–1347(Fig. 5c, elav-Gal4 UAS-Ab1–42 UAS-CAT) had similar beneﬁcial
effects in ﬂies expressing wild-type Ab1–42 (Fig. 5c, elav-Gal4 UAS-
Ab1–42). As expected, ﬂies co-expressing SOD1 (Fig. 5c, elav-Gal4
UAS-Ab1–42 UAS-SOD1) with wild-type Ab1–42 demonstrated an
accelerated decline in locomotor function. The co-expression of GST
(Fig. 5d, elav-Gal4 UAS-Arctic Ab1–42 UAS-GST) gave a weak but
signiﬁcant improvement in locomotor function from day 10 onwards.
Carbonyl reductase (Fig. 5d, elav-Gal4 UAS-Arctic Ab1–42 UAS-SNI)
did not signiﬁcantly improve locomotor function.
The metal chelator clioquinol reduces b-amyloid
peptide-mediated neuronal toxicity and speciﬁcally
reduces iron levels in the brain
That the protection against Ab toxicity afforded by ferritin is mediated
in part by the chelation of Fe
2+ and Fe
3+ ions was investigated
by treating ﬂies expressing Ab1–40, wild-type Ab1–42 and Arctic Ab1–42
with the metal chelator clioquinol (Kaur et al., 2003) (Fig. 6).
Although clioquinol had no effect on the longevity of ﬂies expressing
the non-toxic Ab1–40 (Fig. 6a, circles) there was, in contrast, a clear
dose-related increase in longevity for Arctic Ab1–42 (Fig. 6a, dia-
monds) ﬂies. Expression of wild-type Ab1–42 (Fig. 6a, triangles) gave
an intermediate response to clioquinol treatment with an optimum
dose of approximately of 20 lm. The degree of functional rescue in
ﬂies expressing Arctic Ab1–42 closely reﬂected the concentration of
iron in the extracts of ﬂy heads (Fig. 6b). We found that the presence
of Arctic Ab1–42 (Fig. 6b, triangles) increased the uptake of iron as
compared with control ﬂies (Fig. 6b, circles), a striking effect that is
only completely reversed by treatment with 200 lm clioquinol. The
levels of zinc (1.5–1.7 mm) were the same in Arctic Ab1–42-expressing
and control ﬂies and remained unchanged following clioquinol
treatment. Copper could not be detected in the head extracts.
Oxidative damage in ﬂies expressing b-amyloid peptide is
reduced by ferritin and increased by superoxide dismutase 1
The quantity of carbonyl groups was assessed in ﬂies expressing
Arctic Ab1–42 in the presence or absence of the heavy and light
chains of ferritin. The expression of Arctic Ab1–42 signiﬁcantly
increased the concentration of carbonyl groups (Fig. 7a, elav-Gal4
w
1118 vs. elav-Gal4 UAS-Arctic Ab1–42, P < 0.001) but this was
reduced by 30% following the co-expression of ferritin light chain
(Fig. 7a, elav-Gal4 UAS-Arctic Ab1–42 UAS-FerLC and elav-Gal4
UAS-Arctic Ab1–42, P < 0.01). Remarkably, ferritin heavy chain
(Fig. 7a, elav-Gal4 UAS-Arctic Ab1–42 UAS-FerHC) reduced the
carbonyl level (P < 0.001) almost to that of control ﬂies (Fig. 7a,
control elav-Gal4 UAS-Arctic Ab1–42). These ﬁndings are consistent
with ferritin exerting its suppression of the Ab phenotype by an
antioxidant effect. Conversely, the enhancer effect of SOD1 was
accompanied by a signiﬁcant increase in carbonyl levels in Arctic
Ab1–42 ﬂies (Fig. 7a, elav-Gal4 UAS-Arctic Ab1–42 vs. elav-Gal4
UAS-Arctic Ab1–42 UAS-SOD1, P < 0.01). These data suggest that
the rapid production of H2O2 by cytoplasmic SOD1 can overwhelm
endogenous CAT resulting in the Fe
2+-mediated generation of the
hydroxyl radical (Fenton reaction) that damages proteins as demon-
strated by the increased carbonyl load.
Ferritin subunits suppress the toxicity of b-amyloid peptide1–42
despite increased levels of b-amyloid peptide1–42 in the brain
The effect of over-expressing antioxidant transgenes on the level
of Ab1–42 in the brains of ﬂies was assessed by an enzyme-
linked immunosorbent assay that measured 5 m guanidinium hydro-
chloride-soluble Ab1–42. Six independent lines of ﬂies expressing
Arctic Ab1–42 and carrying GS elements that cause over-expression of
Fig. 6. The iron-chelating compound clioquinol was added to the ﬂy food at ﬁnal concentrations of 2, 20 and 200 lm and its effects on the Ab-associated longevity
phenotype and the accumulation of iron in the ﬂy brain was assessed. The median lifespan of ﬂies expressing Ab1–40 (a, circles) was not signiﬁcantly increased by
clioquinol at any concentration; however, ﬂies expressing Arctic Ab1–42 demonstrated a clear concentration-related increase in median survival (a, diamonds). Wild-
type Ab1–42 ﬂies exhibited an intermediate, but signiﬁcant, response (a, triangles). Kaplan–Meier survival statistics with the log rank test were used to analyse the
data (signiﬁcance of difference from no-clioquinol control, **P < 0.01, ***P < 0.001, unlabelled P > 0.05). Flies expressing Arctic Ab1–42 (b, triangles)
accumulated signiﬁcantly more iron in their brains than control ﬂies (b, circles) and this was only reversed by treatment with 200 lm clioquinol. Error bars show the
SD (n = 3). The signiﬁcance of the difference between clioquinol-treated and non-treated ﬂies was calculated pairwise using the two-tailed Student’s t-test
(**P < 0.01).
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of Ab1–42 in their brains (65 pm in control ﬂies vs. 100 pm for GS
elements co-expressing the light chain gene, P < 0.01, and 141 pm
over-expressing the heavy chain gene, P < 0.01). This elevation of
Ab1–42 when over-expressing ferritin subunits was conﬁrmed in ﬂies
co-expressing Ab1–42 with UAS-linked transgenes for either the heavy
or light chains (Fig. 7b). In contrast, the levels of Ab1–42 were
unaffected by the co-expression of CAT or the over-expression, or the
knockdown, of SOD-1. Thus, the rescue mediated by over-expression
ofoxidativestressgeneswasnotmediatedbysuppressionoftheAb1–42.
Discussion
Two genome-wide genetic screens were used in our Drosophila model
of AD to identify genes that play an important role in the toxicity of
the Ab. The ﬁrst screen, using Drosophila cDNA microarrays,
quantiﬁed the changes in gene transcription that occurred in response
to the expression of Ab1–42 as compared with Ab1–40. The second
complementary screen, using a library of ﬂies with unique GS element
insertions, identiﬁed genes, which when transcriptionally up- or
downregulated modiﬁed the lifespan of ﬂies expressing Ab1–42. Taken
as a whole the GS screen was remarkable for the number of genes
adjacent to modifying P-elements that had redox or antioxidant
activities. Similarly, the cDNA microarray studies showed that redox-
associated transcripts were the most robustly represented functional
group of genes that were differentially regulated by Ab1–42 expression.
This combination of observations is powerful because, whereas the
microarray data provide genetic evidence of a response by the brain to
oxidative stress, the GS screen, in contrast, points to a direct
pathogenic role for oxidative stress in the generation of Ab-related
Fig. 7. Oxidative stress mediated by the Arctic
Ab1–42 is reversed by ferritin despite an increase in the
levels of Ab1–42. A reduction in carbonyl load was
apparent with co-expression of the light chain of
ferritin (a, UAS-FerLC elav-Gal4 UAS-Arctic Ab1–42,
P < 0.05); however, the effect was more marked
following over-expression of the heavy chain of
ferritin (a, UAS-FerHC elav-Gal4 UAS-Arctic Ab1–42,
P < 0.01). In contrast, co-expression of SOD1
(a, UAS-SOD1 elav-Gal4 UAS-Arctic Ab1–42,
P < 0.01) signiﬁcantly increased the oxidative damage
as compared with ﬂies expressing Arctic Ab1–42 alone
(a, control elav-Gal4 UAS-Arctic Ab1–42) (**P < 0.01,
***P < 0.001). The concentration of Ab1–42 in the
heads of ﬂies was determined for three independent
biological replicates for each line of ﬂies.
Co-expression of both the heavy and light chains of
ferritin results in signiﬁcantly increased levels of Ab
(b, UAS-FerLC and UAS-FerHC). In contrast,
modiﬁcation of SOD1 or CAT activity (b, UAS-SOD1,
UAS-SOD1 RNAi and UAS-CAT) has no effect on Ab
levels. Error bars show the SEM.
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emphasized by the remarkably close correlation between the severity
of the phenotypes observed for Ab1–40,A b1–42 and Arctic Ab1–42 and
the oxidative modiﬁcation of brain proteins as determined by
carbonyl levels. These ﬁndings are concordant with the raised levels
of oxidized proteins and lipids in post-mortem AD brains where it is
known that oxidative damage is present from the earliest clinical
stages of the disease (Nunomura et al., 2001; Markesbery et al.,
2005). Our work therefore represents an advance on current clinical
work and mouse models that have not clariﬁed whether oxidative
stress plays a direct role in the pathogenesis of AD or whether it is a
consequence of the disease process. Indeed, the view that oxidative
stress is a bystander effect is supported by clinical trial data that
show, despite early encouraging data from observational studies
(Morris et al., 2002a,b; Zandi et al., 2004) and one prospective trial
(Sano et al., 1997), that the antioxidant vitamin E is not able to
prevent the onset of dementia or prevent progression of established
disease (Petersen et al., 2005).
In this work we have undertaken a molecular dissection of the
oxidative stress pathway (Fig. 8) in order to gain a more detailed
understanding of which oxidative species were of particular impor-
tance in Ab-mediated neurodegeneration. This work has emphasized
three main sources of oxidative stress: ﬁrstly, the generation of
hydroxyl radicals via the Fenton reaction (Smith et al., 1997; Dikalov
et al., 2004), secondly, mitochondrial superoxide levels and thirdly,
reactive aldehyde species produced by lipid oxidation. Although each
of these sources contributes signiﬁcantly to oxidative stress, the
conversion of H2O2 to the hydroxyl radical is the most important toxic
process. The most immediate support for this comes from the
profound protection afforded to ﬂies when CAT is co-expressed with
Ab1–42 because hydroxyl radical generation will predictably be
abolished by converting H2O2 to water.
Only co-expression of ferritin subunits offered a more effective
rescue of the longevity phenotype than CAT. Ferritin proteins are
highly conserved in evolution and have been extensively characterized
(Harrison & Arosio, 1996). Functional ferritin complexes may be
composed of various proportions of heavy and light subunits. For
instance, in the human, ferritin from the brain is predominantly
composed of heavy chain, whereas in the liver the ferritin has a high
proportion of light chain. In our model, the over-expression of Fer1HC
or Fer2LC occurred in the context of endogenous Fer1HC and Fer2LC
expression. Thus, in our transgenic animals we should produce ferritin
complexes composed of both subunits but with one or the other
representing the major component. Remarkably, ferritin heavy chain
was able to restore the longevity and locomotor phenotype of ﬂies
expressing the highly toxic Arctic Ab1–42 to that of control ﬂies. That
this rescue was mediated by an antioxidant effect is supported by the
reductions in carbonyl levels in the brains of ﬂies co-expressing either
the light or, again more potently, heavy chain of ferritin. It is likely that
the sequestration of iron by both ferritin subunits, and the conversion
of Fe
2+ to Fe
3+ by the heavy chain, slows hydroxyl radical production.
Our data show for the ﬁrst time that it is likely to be the removal of
Fe
2+, by the ferroxidase activity of the heavy chain, that is speciﬁcally
beneﬁcial. Previous in-vitro data have shown that synthetic Ab can
directly generate H2O2 in the presence of metal ions (Huang et al.,
1999a; Tabner et al., 2005) and in particular iron (Khan et al., 2006).
Using molecular oxygen as a substrate, the production of H2O2 by
synthetic Ab depends on Fe
2+ ions generated via a redox cycling of
iron (Huang et al., 1999a; Khan et al., 2006). Thus, it is possible that
ferritin can not only prevent the Fenton reaction but additionally the
Fe
2+-scavenging activity of ferritin heavy chain can also protect
neurones against the intrinsic redox properties of Ab (Fig. 8).
The powerful antioxidant properties of ferritin can also rescue
the locomotor deﬁcits associated with Ab expression despite an
accompanying twofold increase in Ab load. These data make the
modulation of brain iron metabolism an attractive therapeutic target
not least because the concentration of Fe
2+ in amyloid plaques is
1m m, almost three times the normal level (Bush, 2003). Furthermore,
clioquinol, a metal chelator, reduces plaque deposition in mouse
models of AD (Cherny et al., 2001), is safe in clinical trials (Ritchie
et al., 2003) and, as we show here, speciﬁcally reduces iron levels in
the brain and prolongs the survival of ﬂies expressing Arctic Ab1–42.
Oxidative stress has been linked with mitochondrial dysfunction in
several neurodegenerative disorders including AD and also Parkin-
son’s and Huntington’s diseases (Bowling & Beal, 1995; Maier &
Chan, 2002). In AD there is evidence that soluble oligomeric
aggregates of Ab may damage the insulating properties of the
neuronal plasma membrane (Kayed et al., 2004) resulting in calcium
inﬂux (Demuro et al., 2005). Mitochondria from patients with AD are
impaired in their ability to buffer calcium inﬂuxes and also show
defects in their respiratory complexes, particularly complex IV,
resulting in increased generation of reactive oxygen species (Sheehan
et al., 1997; Abramov et al., 2004). Our data are consistent with these
hypotheses showing that over-expression of the mitochondrial super-
oxide scavenging enzyme mitSOD2 offered modest but signiﬁcant
protection against Ab toxicity.
Fig. 8. Model of Ab-mediated oxidative stress. CuZn-SOD1 breaks down
superoxide free radicals (O2)) in the cytoplasm to produce H2O2 and molecular
oxygen (O2). In the presence of oxygen, Fe
2+ cycles back to Fe
3+ by the Ab to
produce H2O2.H 2O2 is neutralized into water by CAT. The heavy chain of
ferritin (Fer1HC) has ferroxidase activity, which catalyses the conversion of
Fe
2+ into Fe
3+ ions. Fe
3+ is subsequently stored by the light chain of ferritin
(Fer2LC). Thus, ferritin has two effects: it prevents Fe
2+ from interacting with
the Ab and producing H2O2 and it prevents Fe
2+ from reacting with H2O2 and
producing the free radical hydroxyl (OH
.) via the Fenton reaction. Hydroxyl
radicals can also oxidize lipids to generate long-lived reactive aldehydes.
Carbonyl reductase (CAR) and GST are downstream antioxidant defences that
participate in the detoxiﬁcation of the reactive aldehyde species.
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toxicity of Ab1–42. This result underlines the low toxicity of the
superoxide anion and again emphasizes the importance of H2O2 in
the oxidative stress pathway. By showing that dominant negative
mutants of SOD1 prolong the life of the AD ﬂies, our ﬁndings
demonstrate that SOD1 catalytic activity mediates its toxicity.
Furthermore, RNAi knockdown of SOD1 protein expression did
not provide any additional rescue, indicating that our data are not
confounded by toxicity caused by SOD1 misfolding and aggregation
as is proposed for SOD1-linked familial amyotrophic lateral sclerosis
(Lynch et al., 2004). The ﬁnding of elevated carbonyl levels in the
brains of ﬂies co-expressing SOD1 and Arctic Ab1–42 suggests that
rapid dismutation of superoxide can overwhelm the capacity of
endogenous CAT to remove the consequent H2O2. In addition, the
dismutation of superoxide radicals releases molecular oxygen that
may become a substrate for the Ab-dependent production of H2O2
(Fig. 8). Nevertheless, the enhancer activity of SOD1 in Drosophila
was unexpected because previous studies in a mouse model of AD
showed that SOD1 knockdown caused increased activation of
apoptotic pathways (Chen et al., 2005). Further work is required
to determine whether SOD1 upregulation is toxic in a mammalian
model of AD.
Finally, we have evaluated the effect of two enzymes that are
involved in the detoxiﬁcation of reactive aldehydes (GSTand carbonyl
reductase). Reactive aldehydes, such as 4-oxonon-2-enal, result from
hydroxyl radical-mediated lipid oxidation and accumulate in the brains
of patients with AD (Lovell et al., 1997; Markesbery & Lovell, 1998).
Despite being less reactive than the hydroxyl radical, the greater
stability of the aldehydes permits damage to proteins and DNA over
longer times and distances within the cell. We have shown that
over-expression of GST or carbonyl reductase gave only a modest
rescue of Ab toxicity, suggesting that lipid damage is indeed
downstream of the most important toxic events.
In summary, we have used genetic screens and a candidate gene
approach to dissect the contribution of reactive oxygen species to the
toxicity of Ab in our Drosophila model of AD. We have found that the
primary oxidative stressors are likely to be H2O2 and the consequent
hydroxyl radical. Preventing oxidative stress, speciﬁcally by manip-
ulating iron metabolism, provides a powerful strategy for reducing Ab
toxicity in AD.
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